VEGFA and intracranial hemorrhage: Finally, a single-arm pilot study (NCT02314377) including only two patients with large unresectable sporadic brain AVMs found stable lesion volumes after treatment with bevacizumab, despite effective VEGF blockade, and no intracranial hemorrhage or severe AEs (Muster et al, 2021).